|
ING2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.475500E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.165610E-01 |
| Normal-vs-Stage2 |
3.353200E-01 |
| Normal-vs-Stage3 |
3.304700E-03 |
| Normal-vs-Stage4 |
3.806900E-04 |
| Stage1-vs-Stage2 |
6.806600E-01 |
| Stage1-vs-Stage3 |
8.389800E-02 |
| Stage1-vs-Stage4 |
7.242900E-03 |
| Stage2-vs-Stage3 |
8.045500E-02 |
| Stage2-vs-Stage4 |
1.189800E-02 |
| Stage3-vs-Stage4 |
2.959800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.894100E-02 |
| Normal-vs-AfricanAmerican |
7.407600E-01 |
| Normal-vs-Asian |
4.436100E-02 |
| Caucasian-vs-AfricanAmerican |
6.840800E-01 |
| Caucasian-vs-Asian |
7.295000E-01 |
| AfricanAmerican-vs-Asian |
6.108800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.036200E-03 |
| Normal-vs-Female |
6.105600E-02 |
| Male-vs-Female |
1.125980E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.388410E-01 |
| Normal-vs-Age(41-60Yrs) |
4.250200E-02 |
| Normal-vs-Age(61-80Yrs) |
1.718440E-03 |
| Normal-vs-Age(81-100Yrs) |
9.692800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.924000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.809700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.829600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.798600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.362200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.406800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.044600E-04 |
| Classical-VS-Follicular |
5.679400E-01 |
| Classical-VS-Other |
4.302400E-01 |
| Classical-VS-Normal |
1.298790E-01 |
| Tall-VS-Follicular |
6.444400E-02 |
| Tall-VS-Other |
6.318000E-01 |
| Tall-VS-Normal |
8.35949999999919E-05 |
| Follicular-VS-Other |
6.771400E-01 |
| Follicular-VS-Normal |
9.137900E-02 |
| Other-VS-Normal |
1.212170E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.576600E-03 |
| Normal-vs-N1 |
2.038000E-02 |
| N0-vs-N1 |
6.080600E-01 |
|
|
